{"DataElement":{"publicId":"12285181","version":"1","preferredName":"Estrogen Receptor or Progesterone Receptor Positive per ASCO/CAP Guideline Indicator","preferredDefinition":"Response indicating whether tumor is Estrogen Receptor (ER) and/or Progesterone Receptor (PgR) positive per American Society of Clinical Oncology (ASCO) or College of American Pathologists (CAP) guideline.","longName":"ER_PGR_POSITIVE_IND","context":"NRG","contextVersion":"1","DataElementConcept":{"publicId":"12285179","version":"1","preferredName":"Estrogen Receptor Positive Progesterone Receptor Positive American Society of Clinical Oncology Or College of American Pathologists Guideline","preferredDefinition":"An indication that estrogen receptor alpha expression has been detected in a sample._An indication that progesterone receptor (PRG; PR) expression has been detected in a sample.:The world's leading professional organization representing physicians of all oncology disciplines and subspecialties. ASCO sets the standard for cancer care, supports funding for clinical and translational research, fosters the exchange of information related to cancer, including cancer biology, diagnosis, staging, treatment and psychosocial impact.  ASCO provides training in clinical research and patient care and publishes the Journal of Clinical Oncology._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A member-based physician that serves patients, pathologists, and the public by fostering and advocating best practices in pathology and laboratory medicine._A systematic statement of policy rules or principles. Guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by convening expert panels.","longName":"12285177v1.00:12285178v1.00","context":"NRG","contextVersion":"1","ObjectClass":{"publicId":"12285180","version":"1","preferredName":"Estrogen Receptor Positive Progesterone Receptor Positive","preferredDefinition":"An indication that estrogen receptor alpha expression has been detected in a sample._An indication that progesterone receptor (PRG; PR) expression has been detected in a sample.","longName":"C15492:C15496","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Estrogen Receptor Positive","conceptCode":"C15492","definition":"An indication that estrogen receptor alpha expression has been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Progesterone Receptor Positive","conceptCode":"C15496","definition":"An indication that progesterone receptor (PRG; PR) expression has been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F17436B4-0017-34CF-E053-731AD00A4FFB","latestVersionIndicator":"Yes","beginDate":"2023-01-04","endDate":null,"createdBy":"TSESU","dateCreated":"2023-01-04","modifiedBy":"TSESU","dateModified":"2023-01-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"12285184","version":"1","preferredName":"American Society of Clinical Oncology Or College of American Pathologists Guideline","preferredDefinition":"The world's leading professional organization representing physicians of all oncology disciplines and subspecialties. ASCO sets the standard for cancer care, supports funding for clinical and translational research, fosters the exchange of information related to cancer, including cancer biology, diagnosis, staging, treatment and psychosocial impact.  ASCO provides training in clinical research and patient care and publishes the Journal of Clinical Oncology._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A member-based physician that serves patients, pathologists, and the public by fostering and advocating best practices in pathology and laboratory medicine._A systematic statement of policy rules or principles. Guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by convening expert panels.","longName":"C39319:C37998:C157719:C17564","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"American Society of Clinical Oncology","conceptCode":"C39319","definition":"The world's leading professional organization representing physicians of all oncology disciplines and subspecialties. ASCO sets the standard for cancer care, supports funding for clinical and translational research, fosters the exchange of information related to cancer, including cancer biology, diagnosis, staging, treatment and psychosocial impact.  ASCO provides training in clinical research and patient care and publishes the Journal of Clinical Oncology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"College of American Pathologists","conceptCode":"C157719","definition":"A member-based physician that serves patients, pathologists, and the public by fostering and advocating best practices in pathology and laboratory medicine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Guideline","conceptCode":"C17564","definition":"A systematic statement of policy rules or principles. Guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by convening expert panels.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F1744792-A9C2-362A-E053-731AD00A3391","latestVersionIndicator":"Yes","beginDate":"2023-01-04","endDate":null,"createdBy":"TSESU","dateCreated":"2023-01-04","modifiedBy":"TSESU","dateModified":"2023-01-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F1743227-A622-3465-E053-731AD00A126D","latestVersionIndicator":"Yes","beginDate":"2023-01-04","endDate":null,"createdBy":"TSESU","dateCreated":"2023-01-04","modifiedBy":"TSESU","dateModified":"2023-06-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Is the tumor determined to be ER and/or PgR positive assessed by current ASCO/CAP Guideline Recommendations for hormone receptor testing?","url":null,"context":"NRG"},{"name":"NRG CRF Text 1","type":"Alternate Question Text","description":"Is the tumor ER and/or PgR-positive by current ASCO/CAP guidelines based on local testing results?","url":null,"context":"NRG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F1744792-A9C0-362A-E053-731AD00A3391","latestVersionIndicator":"Yes","beginDate":"2023-01-04","endDate":null,"createdBy":"TSESU","dateCreated":"2023-01-04","modifiedBy":"TSESU","dateModified":"2023-06-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}